Lineage Cell Therape...
NYSEAM:LCTX
$ 1,59
+ $0,08 (5,30%)
1,59 $
+$0,08 (5,30%)
End-of-day quote: 04/14/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,22
Earnings Per Share
$0,06
Revenue Per Share
99,00%
Gross Margin %
$0,38 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,22
Revenue Per Share
$0,06
Gross Margin %
99,00%
Market Cap
$0,38 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-0,28 $-0,09 $-0,12 $-0,15 $-0,26 $-0,14 $-0,08 $-0,36 $-0,17 $0,34 $-0,59
Earnings Earnings $-69,75M $-20,55M $-22,62M $-25,52M $-44,12M $-22,63M $-11,98M $-53,77M $-21,57M $34,95M $-53,35M
RPS Revenue Per Share $0,00 $0,06 $0,04 $0,05 $0,09 $0,03 $0,01 $0,02 $0,03 $0,03 $0,06 $0,08
Revenue Revenue $0,00M $14,56M $9,50M $8,95M $14,70M $4,34M $1,83M $3,52M $4,99M $3,46M $5,92M $7,04M
OCF Operating Cash Flow $0,00M $-19,21M $-23,09M $-28,57M $1,06M $0,00M $0,00M $-31,95M $-30,88M $-30,52M $-42,33M $-44,54M
FCF Free Cash Flow $0,00M $-22,15M $-23,66M $-37,00M $0,65M $0,00M $0,00M $0,00M $-32,30M $0,00M $-44,57M $0,00M
OM Operating Margin 0,00% -149,62% -226,11% -237,04% -129,16% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 99,00% -34,81% 92,50% 95,05% 67,15% 78,92% 88,28% 93,95% 95,14% 93,96% 84,27%
FCFS Free Cash Flow Per Share $0,00 $-0,08 $-0,12 $-0,17 $0,00 $-0,15 $-0,13 $-0,22 $-0,27 $-0,28 $-0,46 $-0,63
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A $0,02M $1,15M $0,54M
Sha. Stocks 249,09M 249,09M 228,36M 188,53M 170,15M 169,71M 161,64M 149,81M 149,36M 126,87M 102,78M 90,42M
×